BCM
CNMD icon

BlueCrest Capital Management’s CONMED CNMD Stock Holding History

BlueCrest Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,856
Closed -$226K – 953
2018
Q3 		$226K Buy
+2,856
New +$221K 0.01% 1204
2018
Q2 		– Sell
-12,346
Closed -$782K – 1532
2018
Q1 		$782K Buy
+12,346
New +$737K 0.02% 567

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlueCrest Capital Management's CNMD Position: Q4 2018 in Review

BlueCrest Capital Management sold out of CONMED (CNMD) in Q4 2018, closing a stake of 2,856 shares — an estimated $226K sold.

BlueCrest Capital Management first reported a position in CNMD in Q1 2018 and held it in 2 quarters. The position peaked at $782K in Q1 2018. 207 funds tracked by Wall St. Rank hold CNMD as of Q4 2018.

  • BlueCrest Capital Management reported no remaining CONMED position as of Q4 2018 after selling out during the quarter.
  • BlueCrest Capital Management sold 2,856 CONMED shares in Q4 2018, an estimated $226K.
  • BlueCrest Capital Management first reported a position in CONMED in Q1 2018 and held it in 2 quarters.
  • BlueCrest Capital Management's CONMED position peaked at $782K in Q1 2018.
  • 207 funds tracked by Wall St. Rank held CONMED as of Q4 2018.

Based on BlueCrest Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.